Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

14 Biggest Mid-Day Gainers For Monday

PSTV, MFIN, WINT, GALT, CYCC, GERN, EVRI, NRBO, STTO, KNX

  • Straight Path Communications Inc (NYSE: STRP) shares jumped 146.7 percent to $90. AT&T Inc. (NYSE: NYSE) announced an agreement to acquire Straight Path in a deal valued at $1.6 billion, including liabilities.
  • Cytori Therapeutics Inc (NASDAQ: CYTX) shares rose 40.15 percent to $1.92 after the company announced that the FDA had approved an Investigational Device Exemption (IDE) for a pilot clinical trial to evaluate Cytori Cell Therapy in patients with thermal burn injury.
  • Axovant Sciences Ltd (NYSE: AXON) shares climbed 28.42 percent to $19.43 after the company named David Hung as its new CEO, effective April 7.
  • Sito Mobile Ltd (NASDAQ: SITO) shares rose 24.64 percent to $2.63. The company had named Lawrence Firestone as its interim CFO last month.
  • Geron Corporation (NASDAQ: GERN) shares were up 19.53 percent to $2.57, after the company announced that a second internal review of imetelstat's ongoing clinical trials for two blood-based malignancies warrants further investigation for both indications.
  • Swift Transportation Co (NYSE: SWFT) shares jumped 22.08 percent to $24.44 on news of the company’s merger with Knight Transportation in an all-stock transaction.
  • Windtree Therapeutics Inc (NASDAQ: WINT) shares rose 11.93 percent to $1.22. The top-line results from phase 2b of the company’s aerosolized KL4 surfactant therapies for respiratory diseases is expected in mid-2017.
  • Galectin Therapeutics Inc (NASDAQ: GALT) shares surged 15.33 percent to $3.31. The company received positive FDA feedback.
  • Everi Holdings Inc (NYSE: EVRI) shares rose 14.58 percent to $5.50 after the company released preliminary Q1 results and announced plans to refinance some of its outstanding debt.
  • Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares rose 12.33 percent to $6.65 after the company reported positive results for its new product for the treatment of lung cancer patients.
  • BioTelemetry, Inc. (NASDAQ: BEAT) shares climbed 13.00 percent to $30.85. The company has entered into a definitive agreement to acquire the outstanding shares of LifeWatch AG.
  • Medallion Financial Corp (NASDAQ: MFIN) shares rose 12.30 percent to $2.07. Research firm Alpha One, which ranks companies on a scale of negative one to positive one, gave Medallion Financial Corp a daily sentiment score of 0.14.
  • Knight Transportation Inc. (NYSE: KNX) shares were up 12.81 percent to $34.58 on news of the company’s merger with Swift Transportation in an all-stock transaction.
  • Gemphire Therapeutics Inc (NASDAQ: GEMP) shares climbed 11.98 percent to $11.50. Jefferies issued its Q1 2017 EPS estimate for Gemphire Therapeutics at ($0.84), while reiterating a Buy rating and a price target of $17.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today